Literature DB >> 10454213

Delineation of selective cyclic GMP-dependent protein kinase Ialpha substrate and inhibitor peptides based on combinatorial peptide libraries on paper.

W R Dostmann1, C Nickl, S Thiel, I Tsigelny, R Frank, W J Tegge.   

Abstract

Peptide libraries on cellulose paper have proven to be valuable tools for the a priori determination of substrate specificities of cyclic AMP- and cyclic GMP-dependent protein kinases (cAMP-kinase and cGMP-kinase) on the basis of octa-peptide sequences. Here, we report the extension of our peptide library screens to 12-mer and 14-mer peptide sequences, resulting in highly cGMP-kinase Ialpha selective peptides. The sequences TQAKRKKSLAMA-amide and TQAKRKKSLAMFLR-amide, with Km values for cGMP-kinase Ialpha of 0.7 and 0.26 microM and Vmax values of 11.5 and 10.9 micromol/min/mg, respectively, display a high specificity for this enzyme. Furthermore, replacing the phosphate acceptor residue serine with alanine in TQAKRKKSLAMA-amide resulted in the highly cGMP-kinase Ialpha selective inhibitor peptide TQAKRKKALAMA-amide, with inhibitor constants for cGMP-kinase Ialpha and cAMP-kinase of 7.5 microM and 750 microM, respectively. Selective cGMP-kinase inhibitors have the potential to play an important role in the elucidation of the distinct cellular functions of cGMP-kinase separate from those activated by cAMP-kinases, and, therefore, may play an important role as pharmaceutical targets. Molecular docking experiments of the most cGMP-kinase selective sequences on a molecular model of the catalytic domain of cGMP-kinase Ialpha suggest that they adopt unique conformations, which differ significantly from those observed for the cAMP-kinase-specific inhibitor PKI(5-24). Our results suggest that despite their structural similarities, cAMP-kinase and cGMP-kinase use distinct peptide substrate and inhibitor conformations, which could account for their unique substrate specificities. These findings are further supported by cAMP- and cGMP-kinase-selective inhibitor analogs with (D)-Ala residues at the inhibitory positions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10454213     DOI: 10.1016/s0163-7258(98)00063-1

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  15 in total

Review 1.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

2.  Synthetic Peptides as cGMP-Independent Activators of cGMP-Dependent Protein Kinase Iα.

Authors:  Thomas M Moon; Nathan R Tykocki; Jessica L Sheehe; Brent W Osborne; Werner Tegge; Joseph E Brayden; Wolfgang R Dostmann
Journal:  Chem Biol       Date:  2015-12-17

3.  Peptide-mediated interference with influenza A virus polymerase.

Authors:  Alexander Ghanem; Daniel Mayer; Geoffrey Chase; Werner Tegge; Ronald Frank; Georg Kochs; Adolfo García-Sastre; Martin Schwemmle
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

Review 4.  Deciphering enzyme function using peptide arrays.

Authors:  Alexandra Thiele; Gabriele I Stangl; Mike Schutkowski
Journal:  Mol Biotechnol       Date:  2011-11       Impact factor: 2.695

5.  The specificity of the protein kinase C alpha, betaII and gamma isoforms as assessed by an unnatural alcohol-appended peptide library.

Authors:  X Yan; K Curley; D S Lawrence
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

6.  Direct modulation of the protein kinase A catalytic subunit α by growth factor receptor tyrosine kinases.

Authors:  George B Caldwell; Alan K Howe; Christian K Nickl; Wolfgang R Dostmann; Bryan A Ballif; Paula B Deming
Journal:  J Cell Biochem       Date:  2012-01       Impact factor: 4.429

7.  Purification and functional analysis of protein kinase G-1α using a bacterial expression system.

Authors:  Saurabh Aggarwal; Ruslan Rafikov; Christine M Gross; Sanjiv Kumar; Daniel Pardo; Stephen M Black
Journal:  Protein Expr Purif       Date:  2011-05-13       Impact factor: 1.650

8.  Alterations in the cerebellar (Phospho)proteome of a cyclic guanosine monophosphate (cGMP)-dependent protein kinase knockout mouse.

Authors:  Eleonora Corradini; Raghavan Vallur; Linsey M Raaijmakers; Susanne Feil; Robert Feil; Albert J R Heck; Arjen Scholten
Journal:  Mol Cell Proteomics       Date:  2014-06-12       Impact factor: 5.911

9.  (D)-Amino acid analogues of DT-2 as highly selective and superior inhibitors of cGMP-dependent protein kinase Ialpha.

Authors:  Christian K Nickl; Shiv Kumar Raidas; Hong Zhao; Matthias Sausbier; Peter Ruth; Werner Tegge; Joseph E Brayden; Wolfgang R Dostmann
Journal:  Biochim Biophys Acta       Date:  2009-12-16

10.  cGMP-dependent protein kinase Ialpha associates with the antidepressant-sensitive serotonin transporter and dictates rapid modulation of serotonin uptake.

Authors:  Jennifer A Steiner; Ana Marin D Carneiro; Jane Wright; Heinrich J G Matthies; Harish C Prasad; Christian K Nicki; Wolfgang R Dostmann; Carrie C Buchanan; Jackie D Corbin; Sharron H Francis; Randy D Blakely
Journal:  Mol Brain       Date:  2009-08-05       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.